Reliable and Sensitive Detection of Fragile X (Expanded) Alleles in Clinical Prenatal DNA Samples with a Fast Turnaround Time  Sara Seneca, Willy Lissens,

Slides:



Advertisements
Similar presentations
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Advertisements

An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
Triplet Repeat Primed PCR Simplifies Testing for Huntington Disease
Mutant Enrichment with 3′-Modified Oligonucleotides
Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology  Marlous Hoogstraat, John W.J. Hinrichs, Nicolle.
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
Validation of a Commercially Available Screening Tool for the Rapid Identification of CGG Trinucleotide Repeat Expansions in FMR1  Grace X.Y. Lim, Yu.
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk.
PCR–Electrospray Ionization Mass Spectrometry
A Pseudo-Full Mutation Identified in Fragile X Assay Reveals a Novel Base Change Abolishing an EcoRI Restriction Site  Shujian Liang, Harold N. Bass,
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
LightCycler Technology in Molecular Diagnostics
Expansion of an FMR1 Grey-Zone Allele to a Full Mutation in Two Generations  Isabel Fernandez-Carvajal, Blanca Lopez Posadas, Ruiqin Pan, Christopher Raske,
Yanggu Shi, Sharon F. Terry, Patrick F. Terry, Lionel G
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification Enables a Rapid and Reliable Distinction between Male FMR1 Premutation and Full-Mutation.
Triplet Repeat Primed PCR Simplifies Testing for Huntington Disease
Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology  Marlous Hoogstraat, John W.J. Hinrichs, Nicolle.
Development and Applications of a BRAF Oligonucleotide Microarray
Bruce E. Hayward, Karen Usdin  The Journal of Molecular Diagnostics 
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
Performance Evaluation of Two Methods Using Commercially Available Reagents for PCR-Based Detection of FMR1 Mutation  Jane S. Juusola, Paula Anderson,
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
A Clinical Grade Sequencing-Based Assay for CEBPA Mutation Testing
Characterization of the Different BCR-ABL Transcripts with a Single Multiplex RT-PCR  Jacques Chasseriau, Jérôme Rivet, Frédéric Bilan, Jean-Claude Chomel,
DNA Diagnostics by Surface-Bound Melt-Curve Reactions
Fragile X Syndrome The Journal of Molecular Diagnostics
Bruce E. Hayward, Yifan Zhou, Daman Kumari, Karen Usdin 
Patrick R. Murray  The Journal of Molecular Diagnostics 
Christine L. Baker, Cecily P. Vaughn, Wade S. Samowitz 
An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
Defining the Performance Parameters of a Rapid Screening Tool for FMR1 CGG-Repeat Expansions Based on Direct Triplet-Primed PCR and Melt Curve Analysis 
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Comprehensive Diagnostic Testing for Stereocilin
Janice M. Spence, Paul G. Rothberg, Nancy Wang, W. Richard Burack 
PCR–Electrospray Ionization Mass Spectrometry
Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
Screening for Expanded Alleles of the FMR1 Gene in Blood Spots from Newborn Males in a Spanish Population  Isabel Fernandez-Carvajal, Paulina Walichiewicz,
An Information-Rich CGG Repeat Primed PCR That Detects the Full Range of Fragile X Expanded Alleles and Minimizes the Need for Southern Blot Analysis 
A Rare Mutation in the Primer Binding Region of the Amelogenin Gene Can Interfere with Gender Identification  Bonnie Shadrach, Mairead Commane, Carol.
A Highly Sensitive Genetic Protocol to Detect NF1 Mutations
Syed Hussain Askree, Lawrence N
Efficient and Highly Sensitive Screen for Myotonic Dystrophy Type 1 Using a One-Step Triplet-Primed PCR and Melting Curve Assay  Mulias Lian, Indhu-Shree.
Jennifer A. Hempelmann, Sheena M. Scroggins, Colin C
A Multi-Exonic BRCA1 Deletion Identified in Multiple Families through Single Nucleotide Polymorphism Haplotype Pair Analysis and Gene Amplification with.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
A Simple, High-Throughput Assay for Fragile X Expanded Alleles Using Triple Repeat Primed PCR and Capillary Electrophoresis  Elaine Lyon, Thomas Laver,
Application of COLD-PCR for Improved Detection of NF2 Mosaic Mutations
Ye Bang-Ce, Chu Xiaohe, Fan Ye, Li Songyang, Yin Bincheng, Zuo Peng 
A Novel Assay for Evaluating Fragile X Locus Repeats
A Novel Methylation PCR that Offers Standardized Determination of FMR1 Methylation and CGG Repeat Length without Southern Blot Analysis  Marina Grasso,
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
Multiplex PCR Detection of GSTM1, GSTT1, and GSTP1 Gene Variants
Feras M. Hantash, Arlene Rebuyon, Mei Peng, Joy B
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Triplet Repeat Primed PCR (TP PCR) in Molecular Diagnostic Testing for Friedreich Ataxia  Paola Ciotti, Emilio Di Maria, Emilia Bellone, Franco Ajmar,
Custom Design of a GeXP Multiplexed Assay Used to Assess Expression Profiles of Inflammatory Gene Targets in Normal Colon, Polyp, and Tumor Tissue  Janice.
Kathleen M. Murphy, Tanya Geiger, Michael J. Hafez, James R
Extra Alleles in FMR1 Triple-Primed PCR
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Characterization of a Recurrent Novel Large Duplication in the Cystic Fibrosis Transmembrane Conductance Regulator Gene  Feras M. Hantash, Joy B. Redman,
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
Presentation transcript:

Reliable and Sensitive Detection of Fragile X (Expanded) Alleles in Clinical Prenatal DNA Samples with a Fast Turnaround Time  Sara Seneca, Willy Lissens, Kristof Endels, Ben Caljon, Maryse Bonduelle, Kathleen Keymolen, Marjan De Rademaeker, Urielle Ullmann, Patrick Haentjens, Kim Van Berkel, Sonia Van Dooren  The Journal of Molecular Diagnostics  Volume 14, Issue 6, Pages 560-568 (November 2012) DOI: 10.1016/j.jmoldx.2012.05.003 Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Schematic representation of the primer locations of the gene-specific PCR (A) and TP-PCR assay (B) in the 5′-untranslated region of the FMR1 gene. The forward and reverse primers amplify the full-length amplicon according to the number of triplet repeats. The TP-PCR assay contains a third chimeric primer in combination with the gene-specific forward and reverse primer pair set, hybridizing randomly within the CGG repeat region and generating numerous amplicons of various sizes in addition to the gene-specific allele fragment(s). The Journal of Molecular Diagnostics 2012 14, 560-568DOI: (10.1016/j.jmoldx.2012.05.003) Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 TP-PCR data of the four different categories: a heterozygous prenatal female DNA sample with two normal alleles (20 or 30 repeats) (A), a heterozygous prenatal female DNA sample with a normal (31 repeats) and an intermediate (55 repeats) allele (B), a prenatal male DNA sample with a PM (approximately 130 to 150 repeats) allele (C), and a heterozygous prenatal female DNA sample with a normal (30 repeats) and an FM allele (D). TP-PCR data of a male clinical mosaic PM/FM DNA sample (E) and a mock mosaic PM/FM DNA sample (F). The pink background indicates the full mutation region, whereas the gray background indicates a normal, intermediate, or premutation region. This color convention facilitates visual confirmation of affected individuals. The Journal of Molecular Diagnostics 2012 14, 560-568DOI: (10.1016/j.jmoldx.2012.05.003) Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Assay sensitivity to low levels of FM alleles by admixing DNA of a normal prenatal sample with DNA from an FM male fetus to give final concentrations of FM content, as indicated in each panel: 10% (A), 5% (B), 3% (C), 2% (D), 1% (E), and 0.5% (F). Repeatable detection of the FM is possible at a mosaic content as low as 3%. Asterisk, normal alleles; arrow, FM alleles. The pink background indicates the full mutation region, whereas the gray background indicates a normal, intermediate, or premutation region. This color convention facilitates visual confirmation of affected individuals. The Journal of Molecular Diagnostics 2012 14, 560-568DOI: (10.1016/j.jmoldx.2012.05.003) Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Assay sensitivity to low levels of PM alleles by admixing DNA of a normal prenatal sample with DNA from a PM male fetus to give final concentrations of FM content as indicated in each panel: 10% (A), 5% (B), 2.5% (C), and 1% (D). Repeatable detection of the PM is possible at a mosaic content as low as 2.5%. Asterisk, normal alleles; arrow, FM alleles. The pink background indicates the full mutation region, whereas the gray background indicates a normal, intermediate, or premutation region. This color convention facilitates visual confirmation of affected individuals. The Journal of Molecular Diagnostics 2012 14, 560-568DOI: (10.1016/j.jmoldx.2012.05.003) Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions